Form 4: Director Jasinski Trades Lemaître Vascular Shares

Director Lawrence J. Jasinski reported transactions involving Lemaître Vascular Inc. common stock, including option exercises and a sale.

Summary

• Lawrence J. Jasinski, a Director at Lemaître Vascular Inc., reported several transactions on May 7, 2026.
• These transactions include the acquisition of common stock through the exercise of stock options at prices of $47.19, $54.65, and $101.12 per share.
• Following these acquisitions, Jasinski sold 3,943 shares of common stock at a price of $110 per share.
• The filing details the number of shares beneficially owned after these transactions, with direct ownership indicated.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While it details insider transactions, including option exercises and a sale, it does not provide new strategic or financial information that would significantly alter the investment outlook.

Positives

• Director Jasinski exercised stock options, indicating potential belief in the company's value at the exercise prices.
• The sale of shares occurred at a price ($110) higher than the exercise prices of the options exercised, suggesting a profitable transaction for the director.
• The director retains a significant number of shares (4,714) after the reported transactions.

Negatives

• Director Jasinski sold a substantial number of shares (3,943), which could be interpreted as a reduction in his direct stake or confidence, although the sale price was favorable.

Future Outlook

No specific forward-looking statements or guidance were provided in this Form 4 filing, which primarily reports past transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. Such filings are closely watched by investors to gauge the sentiment of company insiders regarding their own company's stock.

Stakeholder Impact

• Shareholders may monitor insider transactions for insights into management's confidence in the company's performance.
• The sale of shares by a director could be perceived by some shareholders as a signal, though the context of option exercises and potential personal financial planning is also relevant.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Stock Options, Beneficial Ownership, Lemaître Vascular, Director Transactions, Common Stock